| Literature DB >> 25603349 |
Tao Zhou1, Hisayuki Komaki2, Natsuko Ichikawa3, Akira Hosoyama4, Seizo Sato5, Yasuhiro Igarashi1.
Abstract
The incorporation pattern of biosynthetic precursors into two structurally unique polyketides, akaeolide and lorneic acid A, was elucidated by feeding experiments with 13C-labeled precursors. In addition, the draft genome sequence of the producer, Streptomyces sp. NPS554, was performed and the biosynthetic gene clusters for these polyketides were identified. The putative gene clusters contain all the polyketide synthase (PKS) domains necessary for assembly of the carbon skeletons. Combined with the 13C-labeling results, gene function prediction enabled us to propose biosynthetic pathways involving unusual carbon-carbon bond formation reactions. Genome analysis also indicated the presence of at least ten orphan type I PKS gene clusters that might be responsible for the production of new polyketides.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25603349 PMCID: PMC4306953 DOI: 10.3390/md13010581
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of akaeolide (1) and lorneic acids A (2) and B (3).
Figure 2Conversion of akaeolide (1) to 17-chloroakaeolide (4).
Incorporation of 13C-labeled precursors into 17-chloroakaeolide (4) and lorneic acid A (2).
| Position | 17-chloroakaeolide (4) | Lorneic Acid A (2) | |||||
|---|---|---|---|---|---|---|---|
| Relative Enrichments α | |||||||
| δC | [1-13C]acetate | [2-13C]acetate | [1-13C]propionate | δC | [1-13C]acetate | [1-13C]propionate | |
| 1 | 14.5 | 1.01 | 0.88 | 0.83 | 177.7 | 0.88 | |
| 2 | 19.0 | 1.00 | 1.00 | 1.00 | 38.3 | 1.04 | 1.02 |
| 3 | 28.8 | 1.00 | 1.69 | 121.8 | 1.03 | ||
| 4 | 46.8 | 0.99 | 0.99 | 131.9 | 0.99 | 1.01 | |
| 5 | 75.4 | 1.06 | 0.81 | 131.7 | 0.83 | ||
| 6 | 43.5 | 1.14 | 0.90 | 126.4 | 0.97 | 1.01 | |
| 7 | 203.1 | 1.17 | 2.11 | 127.8 | 1.03 | ||
| 8 | 138.9 | 0.94 | 0.77 | 0.58 | 137.3 | 0.93 | 0.73 |
| 9 | 140.6 | 1.02 | 0.84 | 127.0 | 1.13 | ||
| 10 | 69.0 | 1.04 | 0.61 | 136.1 | 0.80 | 0.81 | |
| 11 | 84.1 | 0.96 | 1.60 | 127.4 | 1.13 | ||
| 12 | 34.7 | 1.03 | 0.87 | 133.7 | 0.90 | 1.00 | |
| 13 | 49.1 | 0.99 | 1.61 | 33.0 | 1.07 | ||
| 14 | 83.1 | 0.99 | 0.90 | 0.94 | 31.6 | 1.02 | 1.00 |
| 15 | 34.7 | 1.00 | 1.03 | 0.87 | 22.3 | 1.04 | |
| 16 | 30.1 | 1.00 | 1.02 | 13.9 | 1.00 | 1.00 | |
| 17 | 63.7 | 0.96 | 1.12 | 21.2 | 1.01 | 0.99 | |
| 18 | 164.5 | 0.94 | 0.79 | ||||
| 19 | 196.4 | 1.02 | 1.07 | ||||
| 20 | 14.5 | 1.01 | 0.88 | 0.83 | |||
| 21 | 25.1 | 1.00 | 0.82 | 0.99 | |||
| 22 | 14.6 | 1.01 | 0.88 | 0.83 | |||
α 13C signal intensity of each peak in the labeled compounds was divided by that of the unlabeled carbon, normalized to give an enrichment ratio. C-2 was chosen as an unlabeled carbon for 17-chloroakaeolide and C-16 for lorneic acids. The numbers in bold type indicate 13C-enriched atoms from 13C-labeled precursors.
Figure 3Incorporation of 13C-labeled precursors into akaeolide (1) and lorneic acid A (2).
Proposed functions of type I PKS genes for akaeolide biosynthesis and neighboring genes.
| Orf8- | Size a | Proposed Function | Protein Homolog, | % b |
|---|---|---|---|---|
| 511 | 413 | ligase | ligase, | 86/92 |
| 512 | 242 | glutamine amidotransferase | glutamine amidotransferase, | 86/91 |
| 513 | 315 | unknown | membrane protein, | 76/83 |
| 514 | 248 | type II thioesterase | thioesterase, | 64/76 |
| 515 c | 294 | methyltransferase | methyltransferase type 12, | 70/82 |
| 516 c | 180 | unknown | GCN5 family acetyltransferase, | 68/78 |
| 517 | 532 | acyl CoA carboxylase α-subunit | carboxyl transferase, | 82/89 |
| 518 c | 947 | transcriptional regulator | hypothetical protein, | 45/57 |
| 519 c | 532 | oxidoreductase | hypothetical protein, | 64/76 |
| 520 | 4917 | type I PKS | putative type I polyketide synthase, | 53/64 |
| 521 | 3601 | type I PKS | polyketide synthase, | 53/64 |
| 522 | 2771 | type I PKS | type I polyketide synthase, | 52/63 |
| 523 | 1322 | type I PKS | hypothetical protein, partial, | 52/61 |
| 524 | 408 | cytochrome P450 | cytochrome P450, | 72/84 |
| 525 | 115 | cyclase | hypothetical protein, | 63/79 |
| 526 | 78 | ferredoxin | hypothetical protein BN6_14320, | 61/73 |
| 527 | 402 | cytochrome P450 | cytochrome P450, | 73/84 |
| 528 | 229 | transcriptional regulator | NmrA family transcriptional regulator, | 76/84 |
| 529 | 498 | transporter | Puromycin resistance protein pur8, partial, | 66/76 |
| 530c | 216 | transcriptional regulator | NmrA family transcriptional regulator, | 70/82 |
| 531 | 109 | transcriptional regulator | HxlR family transcriptional regulator, | 69/83 |
| 532 | 457 | enoyl-CoA reductase/carboxylase | NADPH:quinone reductase, | 79/87 |
| 533 | 340 | 3-oxoacyl ACP synthase | 3-oxoacyl-ACP synthase, | 70/82 |
| 534 | 286 | 3-hydroxyacyl CoA dehydrogenase | 3-hydroxybutyryl-CoA dehydrogenase, | 63/80 |
| 535 | 339 | enoylreductase | putative succinate-semialdehyde dehydrogenase (acetylating), | 68/77 |
| 536 | >213 d | transposase | transposase, | 78/87 |
a in aa; b identity/similarity; c encoded in complementary strand; d located at scaffold terminal.
Figure 4Gene organization of the akaeolide biosynthetic gene cluster of Streptomyces sp. NPS554 (a) and its orthologous gene cluster in Lechevalieria aerocolonigenes NBRC 13195T (b).
Figure 5PKS domain organization and plausible biosynthetic pathway for akaeolide.
Figure 6Gene organization of the biosynthetic gene cluster for lorneic acids.
Proposed functions of type I PKS genes for lorneic acid biosynthesis and neighboring genes.
| Orf1- | Size a | Proposed Function | Protein Homolog, | % b |
|---|---|---|---|---|
| 245 | 372 | transcriptional regulator | transcriptional regulator, | 80/89 |
| 246 | 376 | unknown | hypothetical protein, | 76/84 |
| 247 | 255 | ABC transporter | sugar ABC transporter ATP-binding protein, | 79/86 |
| 248 | 418 | ABC transporter | ABC transporter permease, | 74/82 |
| 249 | 138 | unknown | hypothetical protein AOR_1_82014, | 50/60 |
| 250 c | 185 | unknown | hypothetical protein, | 24/43 |
| 251 c | 158 | unknown | hypothetical protein, | 56/66 |
| 252 c | 239 | unknown | hypothetical protein, | 60/70 |
| 253 | 3128 | type I PKS | hypothetical protein, | 59/70 |
| 254 | 3893 | type I PKS | hypothetical protein, | 58/69 |
| 255 | 2176 | type I PKS | hypothetical protein, | 68/78 |
| 256 | 5477 | type I PKS | hypothetical protein, | 62/72 |
| 257 | 534 | cytochrome P450 | cytochrome P450, | 73/84 |
| 258 | 588 | unknown | hypothetical protein (glycosidase), | 79/87 |
| 259 | 435 | unknown | beta-lactamase, | 80/87 |
| 260 c | 118 | unknown | PDZ and LIM domain protein 1, partial, | 31/52 |
| 261 c | 254 | methyltransferase | methyltransferase, | 84/89 |
| 262 | 148 | transcriptional regulator | Rrf2 family transcriptional regulator, | 78/86 |
| 263 | 486 | transporter | MFS transporter, | 68/80 |
| 264 c | 250 | short-chain dehydrogenase | short-chain dehydrogenase, | 92/94 |
| 265 | 331 | transcriptional regulator | AraC family transcriptional regulator, | 92/94 |
a in aa; b identity/similarity; c encoded in complementary strand.
Figure 7Proposed biosynthetic pathway for lorneic acids.
Figure 8Predicted structures of linear products of orphan type I PKS gene clusters in Streptomyces sp. NPS554.